Histological sampling
Animals that survived for more than 50 weeks were included in the effective numbers because the first tumour of the glandular stomach was found in a rat in group 2 that died in week 50. All surviving rats were killed at the end of the experiment in week 52 and examined at autopsy: ten rats from each group were used for cancer study and apoptosis study, and the remaining ten rats from each group for cancer study and bromodeoxyuridine (BrdU)-labelling study. The stomach and other major organs were carefully examined. The stomach was opened along the greater curvature, pinned flat on a cork mat, and fixed with a picric acid-formaldehyde solution for histological examination. The stomach was cut into longitudinal strips 3 mm in width. The specimens were embedded in paraffin, and 5-µm thick serial sections were stained with haematoxylin and eosin for cancer study and with an Apotag kit for apoptosis. The sections were examined without knowledge of the group to which they belonged.
Definition and classification of gastric cancers
Histologically, adenocarcinomas were defined as lesions in which neoplastic cells had penetrated the muscularis mucosae to invade the submucosa or deeper layers. As previously reported (Tatsuta et al, 1988) , adenocarcinomas were classified as very well differentiated, well differentiated, or poorly differentiated.
Determination of labelling index
The labelling index and also the incidence and number of the gastric cancers were examined in the remaining ten rats from each group in week 52. The labelling index was determined with an immunohistochemical analysis kit for assaying BrdU incorporation (Becton-Dickinson Immunocytometry Systems, Mountain View, CA, USA) (Gratzner et al, 1982; Morstyn et al, 1983) . Briefly, non-fasted rats received a s.c. injection of 1 ml kg -1 body weight of olive oil (groups 1 and 2), 0.75 mg kg -1 body weight of RA (groups 3 and 5), or 1.5 mg kg -1 body weight of RA (groups 4 and 6). One hour later, the rats were given an i.p. injection of 20 mg kg -1 body weight of BrdU and killed with ether 1 h later. The stomach was fixed in 70% ethanol in 2 N hydrochloric acid for 30 min at room temperature and then in 0.1 M sodium borate to neutralize the acid. The sections were immersed in methanol containing 3% hydrogen peroxide for 30 min and treated with 10% horse serum. Next, the sections were stained with anti-BrdU monoclonal antibody (diluted 1:100) for 2 h at room temperature, and then with biotin-conjugated horse anti-mouse antibody (diluted 1:200) for 30 min. The reaction product was localized with 3,3′-diaminobenzidine tetrahydrochloride. The BrdU-labelled cells were identified by the presence of dark pigment over the nuclei.
The labelling index of the gastric cancers was determined by counting the number of BrdU-labelled and unlabelled cells among 500 cancer cells. The labelling index was expressed as the percentage of BrdU-labelled cells among total number of cancer cells.
Determination of apoptotic index
The 3′ end-labelling of apoptotic cell DNA was performed with an ApoTag in situ apoptosis detection kit (Oncor, Gaithersburg, MD, USA) (Törmänen et al, 1995) as follows: after dewaxing and dehydration, the sections were incubated with 20 µg ml -1 proteinase K (Boehringer Mannheim, Mannheim, Germany) at room temperature for 15 min. Endogenous peroxidase activity was quenched in 2% hydrogen peroxide in phosphate-buffered saline (pH 7.2). Terminal transferase was used to catalyse the addition of digoxigenin-labelled nucleotides to the 3′-hydroxy ends of the fragmented DNA. Antidigoxigenin-peroxidase solution was then applied to the slides. Diaminobenzidine-hydrogen peroxide was used to develop the colour reaction. The specimens were counterstained lightly with haematoxylin.
The relative number of apoptotic cells in the total tumour cell population was determined by counting the number of apoptotic cells per ×10 high power field. The index was expressed as a percentage of the tumour cells examined.
Immunohistochemical observation of TGF-α
Immunohistochemistry was performed with the mouse monoclonal antibody AB-2 (Oncogene Science, Cambridge, UK), which is specific for human and rat TGF-α and exhibits no crossreactivity to epidermal growth factor (Livingstone et al, 1994) . Sections were predigested with trypsin for 15 min to expose the antigenic sites before incubation with AB-2 at a dilution of 5:100 overnight at 4°C. After washing with Tris-buffered saline, rabbit anti-mouse serum (Dako, UK) and streptavidin peroxidase complex (Dako) were added at dilutions of 1:333 and 1:400, respectively, for 30 min each before application of diaminobenzidine and counterstaining with haematoxylin. After dehydration in alcohol, the sections were cleared with xylene, and mounted in diphthalate xylene. A positive control section was incubated in each batch to ensure consistency of staining. Two types of negative controls were used: in the first, the primary antibody was replaced by Tris-buffered saline; in the second, specific controls were performed by preincubation of the sections with an excess of the TGF-α peptide PF 008 (Oncogene Science).
TGF-α immunoreactivity was classified as follows: (2+), strong TGF-α expression; (+), weak TGF-α expression; and (-), no TGF-α expression.
Statistical analysis
The data were analysed with the chi-squared test, Fisher's exact probability test, or one-way analysis of variance with Dunn's multiple comparison (Miller et al, 1966) . The data are shown as means ± s.e. Differences were considered significant when the calculated P-value was less than 0.05.
RESULTS

Incidence, number, histological type, and depth of involvement of gastric cancers
All of the animals were included in the effective numbers because none died before experimental week 50. In week 52, there was no significant difference between the six groups in the body weight of the rats (Table 1) .
The incidence, but not the number, of gastric cancers was significantly higher in group 2 (sodium chloride alone; 85%) than in control group 1 (35%) ( Table 1) . Administration of both sodium chloride and 0.75 (group 3) or 1.5 mg kg -1 body weight (group 4) of RA significantly reduced the incidence of gastric cancers compared with the results for group 2. Administration of RA alone at either 0.75 (group 5) or 1.5 mg kg -1 body weight (group 6) had no significant effect on the incidence or number of gastric cancers when compared with control group 1.
All tumours induced in the glandular stomach were histologically classified as adenocarcinomas (Table 2 ). There was no significant difference between the six groups in the histological type of the adenocarcinomas. No poorly differentiated cancers were found. Nor was there any significant difference between the six groups in the depth of involvement of the gastric cancers. All of the cancers were found in the antral mucosa and no metastases were found in any of the rats.
Labelling index, apoptotic index and TGF-α A diet containing 10% sodium chloride (group 2) significantly increased the labelling index and TGF-α immunoreactivity, but decreased the apoptotic index of gastric cancers compared with control group 1 ( Table 3) . Administration of both sodium chloride and 0.75 (group 2) or 1.5 mg kg -1 body weight (group 3) of RA significantly decreased the labelling index and TGF-α immunoreactivity of the gastric cancers, which were increased by administration of sodium chloride, and increased the apoptotic index, which was reduced by administration of sodium chloride. Administration of RA alone at either 0.75 (group 5) or 1.5 mg kg -1 body weight (group 6) had no significant effect on the labelling a Treatment: group 1, the rats were given regular chow pellets and s.c. injections of 1 ml kg -1 of olive oil only every other day after 25 weeks of MNNG treatment; group 2, the rats were given chow pellets containing 10% sodium chloride and s.c. injections of 1 mg kg -1 of olive oil only every other day after 25 weeks of MNNG treatment; groups 3 and 4, the rats were given chow pellets containing 10% sodium chloride and s.c. injections of RA (all-trans-retinoic acid) at doses of 0.75 and 1.5 mg kg -1 body weight, respectively, every other day; groups 5 and 6, the rats were given regular chow pellets and s.c. injections of RA at doses of 0.75 or 1.5 mg kg -1 body weight, respectively, every other day after 25 weeks of MNNG treatment. b Significantly different from the value for group 1 at P < 0.01. c Significantly different from the value for group 2 at P < 0.01. (80) 5 (20) 15 (60) 10 (40) 3 Sodium chloride + RA 0.75 mg kg -1 9 8 (89) 1 (11) 8 (89) 1 (11) 4 Sodium chloride + RA 1.5 mg kg -1 7 7 (100) 0 (0) 7 (100) 0 (0) 5 RA 0.75 mg kg -1 10 10 (100) 0 (0) 10 (100) 0 (0) 6 RA 1.5 mg kg -1 10 9 (90) 1 (10) 10 (100) 0 (0) a For an explanation of treatments, see Table 1 . Sodium chloride + RA 1.5 mg kg -1 32.2 ± 1.6 f 8.7 ± 0.5 f 7 5 (71) (9.4 ± 0.2) 2 (29) d (7.0 ± 0.0) g 5 RA 0.75 mg kg -1 22.4 ± 1.1 9.6 ± 0.5 7 7 (100) 0 (0) 6 RA 1.5 mg kg -1 23.0 ± 2.0 10.6 ± 0.7 6 6 (100) 0 (0) a For an explanation of treatments, see Table 1 . b Significantly different from the value for group 1 at P < 0.001. c-f Significantly different from the value for group 2: c P < 0.05, d P < 0.02, e P < 0.01, f P < 0.001. g Significantly different from the value for cancers without TGF-α immunoreactivity at P < 0.01.
index, apoptotic index, or TGF-α immunoreactivity of the gastric cancers. In groups 3 and 4, gastric cancers with positive immunoreactivity of TGF-α had a significantly lower apoptotic index than that of cancers without TGF-α immunoreactivity.
DISCUSSION
The results of the present study show that RA at lower and higher doses attenuates gastric carcinogenesis enhanced by sodium chloride. These findings indicate that RA at 0.75 mg kg -1 body weight already provided complete protection against sodium chlorideenhanced gastric carcinogenesis. Therefore, it is still unclear at which concentration RA starts to protect. The mechanism of action of retinoids on tumours appears to be related to their effect on the proliferation and differentiation of the tumour cells themselves (Lippman et al, 1987; Jetten et al, 1990; Lotan, 1994; LiaudetCoopman et al, 1997 ). The present study shows that two other mechanisms may be involved in attenuation of gastric carcinogenesis enhanced by sodium chloride. One is induction of apoptosis by administration of RA. Retinoids have been shown to induce apoptosis in haematological and neuroblastoma models (Delia et al, 1993; Ponzoni et al, 1995) . LiaudetCoopman et al (1997) examined the effect of RA on the growth of the ME-1080 cervical squamous cell carcinoma cell line as a s.c. tumour xenograft in athymic nude mice and found that RA treatment induced apoptosis of the tumour cells and led to a decrease in the tumour growth rate. In a study of the effect of RA and 13-cisretinoic acid on the MCF-7, 2R-75-1 and MDA-MB-231 human breast-cancer cell lines, Toma et al (1997) found that both retinoic acids exerted appreciable dose-dependent growth inhibition, and that the antiproliferative activity of RA was more pronounced than that of 13-cis-retinoic acid in all three cell lines tested. Their results also showed that both retinoic acids induced apoptosis in the MCF-7 and MDA-MB-231 cell lines, but not in 2R-75-1. In the present study, combined administration of sodium chloride and RA significantly increased the apoptotic index of the gastric cancers that was reduced by administration of sodium chloride.
A second mechanism that may play a role in the attenuation by RA of gastric carcinogenesis enhanced by sodium chloride is the decrease in TGF-α expression in tumours produced by administration of RA. Livingstone et al (1994) found that the carcinogen MNNG significantly increased the intensity of TGF-α expression in the gastric mucosa and in adenocarcinomas. TGF-α is a 50-amino-acid peptide first isolated from fibroblasts transformed by rodent sarcoma viruses (De Larco and Todaro, 1978) which acts as a ligand for the epidermal growth factor receptor (Derynck, 1986) . TGF-α has the ability to induce malignant transformation in some epithelial cells (McGeady et al, 1989; Shankar et al, 1989) . Miller et al (1996) found that vitamin A suppresses the proliferation of tracheobronchial epithelial cells in culture by inhibiting expression of the TGF-α gene product. They also noted that similar inhibition of the TGF-α mRNA level by retinol was observed in airway explant cultures and in a cell line immortalized from normal human bronchial epithelial cells. The present study showed that combined administration of sodium chloride and RA significantly decreased the TGF-α immunoreactivity of the gastric cancers that was increased by administration of sodium chloride.
In the present study, however, RA treatment does not influence the underlying tumour incidence in the absence of sodium chloride treatment, nor the apoptotic index in these tumours. Therefore, it is possible that tumours with a lower apoptotic index and higher proliferation rates are selected by sodium chloride treatment, and these are, in turn, selectively inhibited by RA treatment.
The results of the present study showed that administration of RA attenuated gastric carcinogenesis, which was enhanced by the administration of sodium chloride. The findings suggest that both increased apoptosis and decreased expression of TGF-α may be closely related to attenuation of gastric carcinogenesis by RA.
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